These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24372238)

  • 1. PET imaging to monitor cancer therapy.
    Malviya G; Nayak TK
    Curr Pharm Biotechnol; 2013; 14(7):669-82. PubMed ID: 24372238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging Studies.
    Zeng C; McDonald ES; Mach RH
    Handb Exp Pharmacol; 2017; 244():309-330. PubMed ID: 28176045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can PET imaging facilitate optimization of cancer therapies?
    Kramer-Marek G; Capala J
    Curr Pharm Des; 2012; 18(18):2657-69. PubMed ID: 22512443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical translation of molecular imaging agents used in PET studies of cancer.
    Kenny LM; Aboagye EO
    Adv Cancer Res; 2014; 124():329-74. PubMed ID: 25287694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic PET Imaging in Oncology.
    Sai KKS; Zachar Z; Bingham PM; Mintz A
    AJR Am J Roentgenol; 2017 Aug; 209(2):270-276. PubMed ID: 28463521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
    Apostolova I; Wedel F; Brenner W
    Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular probes for malignant melanoma imaging.
    Ren G; Pan Y; Cheng Z
    Curr Pharm Biotechnol; 2010 Sep; 11(6):590-602. PubMed ID: 20497118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological aspects on hypoxia PET acquisition and image processing.
    Thorwarth D; Mönnich D; Zips D
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):235-43. PubMed ID: 24045620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.
    Pantel AR; Mankoff DA
    Cancer Lett; 2017 Feb; 387():25-31. PubMed ID: 27195912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
    Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.
    Wijsman R; Kaanders JH; Oyen WJ; Bussink J
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):244-56. PubMed ID: 24045621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring response with FDG-PET: methodological aspects.
    Allen-Auerbach M; Weber WA
    Oncologist; 2009 Apr; 14(4):369-77. PubMed ID: 19357228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of Tumor Characteristics and Molecular Pathways With PET: Developments Over the Last Decade Toward Personalized Cancer Therapy.
    Marcu LG; Moghaddasi L; Bezak E
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1165-1182. PubMed ID: 29907486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy.
    Sharma P; Kumar R; Alavi A
    PET Clin; 2015 Oct; 10(4):495-505. PubMed ID: 26384596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technologies and directed agents for applications of cancer imaging.
    Atri M
    J Clin Oncol; 2006 Jul; 24(20):3299-308. PubMed ID: 16829654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron Emission Tomography Imaging of Tumor Proliferation and DNA Repair.
    Shields AF; Chen DL
    Cancer J; 2024 May-Jun 01; 30(3):170-175. PubMed ID: 38753751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
    Shen B; Huang T; Sun Y; Jin Z; Li XF
    Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-photon emission computed tomography tracers for predicting and monitoring cancer therapy.
    Cai J; Li F
    Curr Pharm Biotechnol; 2013; 14(7):693-707. PubMed ID: 24372237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.